The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Neumann Mark since 2019.
This trader's CIK number is 1756211.
At the time of last reporting, Neumann Mark was the EVP, Chief Commercial Officer of Intra-cellular Therapies, Inc.. (stock ticker symbol ITCI).
Also see all insider trading activities at Intra-cellular Therapies, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ITCI | 0 | $0 | 0 | $0 | 29,220 | $0 |
| 2024 | ITCI | 0 | $0 | 58,958 | $4,112,938 | 47,098 | $690,359 |
| 2023 | ITCI | 0 | $0 | 140,790 | $7,727,880 | 108,443 | $1,668,517 |
| 2022 | ITCI | 0 | $0 | 126,341 | $7,441,508 | 126,341 | $1,099,210 |
| 2021 | ITCI | 0 | $0 | 28,316 | $1,052,540 | 45,535 | $0 |
| 2020 | ITCI | 0 | $0 | 6,792 | $182,025 | 34,395 | $0 |
| 2019 | ITCI | 0 | $0 | 6,774 | $55,885 | 13,448 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-06 | ITCI | Option Ex | 13,133 | .00 | 0 |
| 2025-03-10 | ITCI | Option Ex | 7,345 | .00 | 0 |
| 2025-03-01 | ITCI | Option Ex | 8,742 | .00 | 0 |
| 2024-08-16 | ITCI | Sale | 18,714 | 75.08 | 1,405,047 |
| 2024-08-16 | ITCI | Option Ex | 18,714 | 36.89 | 690,359 |
| 2024-03-10 | ITCI | Option Ex | 7,345 | .00 | 0 |
| 2024-03-07 | ITCI | Sale | 13,132 | 66.66 | 875,379 |
| 2024-03-11 | ITCI | Sale | 7,345 | 65.96 | 484,498 |
| 2024-03-06 | ITCI | Option Ex | 13,132 | .00 | 0 |
| 2024-02-26 | ITCI | Sale | 7,907 | 69.87 | 552,446 |
| 2024-02-23 | ITCI | Option Ex | 7,907 | .00 | 0 |
| 2024-02-02 | ITCI | Sale | 11,860 | 67.08 | 795,568 |
| 2023-11-06 | ITCI | Sale | 42,393 | 55.50 | 2,352,811 |
| 2023-11-06 | ITCI | Option Ex | 26,754 | 23.94 | 640,490 |
| 2023-08-07 | ITCI | Option Ex | 55,300 | 18.59 | 1,028,027 |
| 2023-08-07 | ITCI | Sale | 55,300 | 58.79 | 3,251,087 |
| 2023-03-28 | ITCI | Sale | 15,604 | 54.44 | 849,403 |
| 2023-03-10 | ITCI | Option Ex | 7,344 | .00 | 0 |
| 2023-03-10 | ITCI | Sale | 8,550 | 43.12 | 368,676 |
| 2023-03-13 | ITCI | Sale | 3,758 | 44.58 | 167,512 |
| 2023-03-01 | ITCI | Sale | 7,241 | 50.01 | 362,122 |
| 2023-02-23 | ITCI | Option Ex | 7,906 | .00 | 0 |
| 2023-02-24 | ITCI | Sale | 4,046 | 47.12 | 190,647 |
| 2023-02-21 | ITCI | Sale | 3,898 | 47.62 | 185,622 |
| 2023-02-18 | ITCI | Option Ex | 11,139 | .00 | 0 |
| 2022-04-08 | ITCI | Option Ex | 86,348 | 12.73 | 1,099,210 |
| 2022-04-08 | ITCI | Sale | 86,348 | 64.37 | 5,558,220 |
| 2022-02-24 | ITCI | Sale | 7,906 | 52.10 | 411,902 |
| 2022-02-23 | ITCI | Option Ex | 7,906 | .00 | 0 |
| 2022-02-22 | ITCI | Sale | 11,139 | 55.22 | 615,095 |
| 2022-02-18 | ITCI | Option Ex | 11,139 | .00 | 0 |
| 2022-01-10 | ITCI | Sale | 20,948 | 40.88 | 856,291 |
| 2022-01-08 | ITCI | Option Ex | 20,948 | .00 | 0 |
| 2021-10-15 | ITCI | Option Ex | 13,448 | .00 | 0 |
| 2021-10-18 | ITCI | Sale | 13,448 | 40.15 | 539,869 |
| 2021-02-18 | ITCI | Option Ex | 11,139 | .00 | 0 |
| 2021-02-19 | ITCI | Sale | 5,184 | 39.08 | 202,590 |
| 2021-01-08 | ITCI | Option Ex | 20,948 | .00 | 0 |
| 2021-01-11 | ITCI | Sale | 9,684 | 32.02 | 310,081 |
| 2020-10-16 | ITCI | Sale | 6,792 | 26.80 | 182,025 |
| 2020-10-15 | ITCI | Option Ex | 13,448 | .00 | 0 |
| 2020-01-08 | ITCI | Option Ex | 20,947 | .00 | 0 |
| 2019-10-16 | ITCI | Sale | 6,774 | 8.25 | 55,885 |
| 2019-10-15 | ITCI | Option Ex | 13,448 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Neumann Mark (EVP, Chief Commercial Officer of Intra-cellular Therapies, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.